Of the Aetna members treated by Equip since 2021, 86% have made progress in their eating disorder treatment, and the average reduction in eating disorder symptoms is 70%.
Glucagon is indicated for the treatment of severe hypoglycemia in patients with diabetes mellitus and as a diagnostic aid for use during certain radiologic examinations.